<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04755140</url>
  </required_header>
  <id_info>
    <org_study_id>20-008408</org_study_id>
    <secondary_id>R01AG060920</secondary_id>
    <secondary_id>R01HL147155-02</secondary_id>
    <nct_id>NCT04755140</nct_id>
  </id_info>
  <brief_title>Endoprosthesis Metal Toxicity Study</brief_title>
  <official_title>Evaluation and Clinical Impact of Serum and Blood Metal Ion Levels in Patients With an Endoprosthesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research is to investigate whether patients who previously had&#xD;
      endoprosthesis surgery experience memory, thinking, or heart problems. It will also help&#xD;
      determine how often these problems occur.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      At your first visit you will be asked to do the following:&#xD;
&#xD;
        1. Sign the consent document.&#xD;
&#xD;
        2. Patient Interview: An interview will be conducted by the study coordinator on the&#xD;
           research team. They will ask your past surgical history, health history, medications,&#xD;
           and your cognition.&#xD;
&#xD;
        3. Informant Interview: A close friend, spouse of relative of you will be interviewed about&#xD;
           your day-day cognition.&#xD;
&#xD;
        4. Memory Interview: You will be evaluated on your memory and thinking skills three total&#xD;
           times. One to determine baseline, and then repeated at one year and two years. You will&#xD;
           answer questions that evaluate various thinking abilities such as concentration, memory,&#xD;
           reasoning, and learning.&#xD;
&#xD;
        5. Blood Draw: You will have a blood draw three times (4.2-5 tablespoons) to determine your&#xD;
           baseline, 1 year, and 2 year research results.&#xD;
&#xD;
      6: Echocardiogram: You will be asked to have three echocardiograms. One to determine&#xD;
      baseline, and then repeated at one year and two years.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 12, 2021</start_date>
  <completion_date type="Anticipated">January 2024</completion_date>
  <primary_completion_date type="Anticipated">January 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Echo - Left Ventricular Ejection Fraction</measure>
    <time_frame>Echo's will be taken at baseline, 1 year, and 2 years</time_frame>
    <description>The echocardiogram will measure changes in LV ejection fraction as a percent.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Echo - Left Ventricular Mass</measure>
    <time_frame>Echo's will be taken at baseline, 1 year, and 2 years</time_frame>
    <description>The echocardiogram will measure changes in LV Mass in grams.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Echo - Heart Hypertrophy</measure>
    <time_frame>Echo's will be taken at baseline, 1 year, and 2 years</time_frame>
    <description>The echocardiogram will measure changes in concentric or eccentric hypertrophy in centimeters.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cobalt Metal Levels</measure>
    <time_frame>Cobalt level will be measured at baseline, 1 year, and 2 years</time_frame>
    <description>The change in cobalt blood ion levels will be measured in ng/mL.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Chromium Metal Levels</measure>
    <time_frame>Chromium level will be measured at baseline, 1 year, and 2 years</time_frame>
    <description>The change in chromium blood ion levels will be measured in ng/mL.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Titanium Metal Levels</measure>
    <time_frame>Titanium level will be measured at baseline, 1 year, and 2 years</time_frame>
    <description>The change in titanium blood ion levels will be measured in ng/mL.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Psychometrist Testing - Intelligence Score</measure>
    <time_frame>Testing will occur at baseline, 1 year, and 2 years.</time_frame>
    <description>The change in participants' intelligence will be measured using the Wechsler Adult Intelligence Scale. The scale is based of scores of 50 to 150. The higher the score the better the outcome. The average outcome will be a score of 100.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychometrist Testing - Memory Score</measure>
    <time_frame>Testing will occur at baseline, 1 year, and 2 years.</time_frame>
    <description>The change in participants' memory will be measured using the Wechsler Adult Memory Scale. The scale is based of scores of 50 to 150. The higher the score the better the outcome. The average outcome will be a score of 100.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Bone Tumor</condition>
  <condition>Cancer of Bone</condition>
  <condition>Heart Diseases</condition>
  <condition>Cognitive Impairment</condition>
  <condition>Cognitive Decline</condition>
  <condition>Chemotherapy Effect</condition>
  <condition>Memory Problem</condition>
  <arm_group>
    <arm_group_label>Endoprosthesis</arm_group_label>
    <description>Patients with a endoprosthesis</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Questionnaires</intervention_name>
    <description>The patient and an informant will be asked to complete a questionnaire about his or hers current and past physical thinking abilities.</description>
    <arm_group_label>Endoprosthesis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Interviews</intervention_name>
    <description>Cognition and memory interviews will take place with the patient.</description>
    <arm_group_label>Endoprosthesis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Blood Test</intervention_name>
    <description>Three blood draws will occur to assess patients immune response, metal levels, and cardiac health.</description>
    <arm_group_label>Endoprosthesis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Echocardiogram</intervention_name>
    <description>Each echocardiogram takes about 3 hours and 30 minutes. This test uses sound waves to look at your heart. The person doing the test will press on your chest with a machine to obtain the pictures. The pressure may be uncomfortable. The echocardiogram will involve an image enhancement agent infusion to obtain better images.</description>
    <arm_group_label>Endoprosthesis</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood will be collected from patients and ran through a CyTOF procedure to identify immune&#xD;
      cells within the samples.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        150 patients to complete cardiology part of the study (questionnaires, blood test,&#xD;
        echocardiogram).&#xD;
&#xD;
        150 patients to complete cognitive part of the study (questionnaires, interviews, blood&#xD;
        test).&#xD;
&#xD;
        Patient groups may overlap.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient has an endoprosthesis after extremity malignancy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Current fracture or infection around the endoprosthesis&#xD;
&#xD;
          -  Patient is pregnant&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthew Houdek, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Peter C Brennan</last_name>
    <phone>507-284-4430</phone>
    <email>brennan.peter@mayo.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter C Brennan</last_name>
      <phone>507-284-4430</phone>
      <email>brennan.peter@mayo.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>January 28, 2021</study_first_submitted>
  <study_first_submitted_qc>February 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 15, 2021</study_first_posted>
  <last_update_submitted>April 5, 2021</last_update_submitted>
  <last_update_submitted_qc>April 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Matthew T. Houdek</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Endoprosthesis</keyword>
  <keyword>Metallosis</keyword>
  <keyword>Toxicity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bone Neoplasms</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

